Urine proteomics identifies biomarkers for diabetic kidney disease at different stages

BACKGROUND: Type 2 diabetic kidney disease is the most common cause of chronic kidney diseases (CKD) and end-stage renal diseases (ESRD). Although kidney biopsy is considered as the ‘gold standard’ for diabetic kidney disease (DKD) diagnosis, it is an invasive procedure, and the diagnosis can be inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Guanjie, Gong, Tongqing, Lin, Yuping, Wang, Jianping, Sun, Lu, Wei, Hua, Yang, Xing, Liu, Zhenjie, Li, Xinliang, Zhao, Ling, Song, Lan, He, Jiali, Liu, Haibo, Li, Xiuming, Liu, Lifeng, Li, Anxiang, Lu, Qiyun, Zou, Dongyin, Wen, Jianxuan, Xia, Yaqing, Wu, Liyan, Huang, Haoyue, Zhang, Yuan, Xie, Wenwen, Huang, Jinzhu, Luo, Lulu, Wu, Lulu, He, Liu, Liang, Qingshun, Chen, Qubo, Chen, Guowei, Bai, Mingze, Qin, Jun, Ni, Xiaotian, Tang, Xianyu, Wang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903606/
https://www.ncbi.nlm.nih.gov/pubmed/34963468
http://dx.doi.org/10.1186/s12014-021-09338-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903606/
https://www.ncbi.nlm.nih.gov/pubmed/34963468
http://dx.doi.org/10.1186/s12014-021-09338-6

Ejemplares similares